PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Symptom | C0033817|pseudomonas infection |
| Sentences | 3 |
| PubMedID- 22029514 | Aztreonam lysinate has been shown to ameliorate pulmonary function in cystic fibrosis patients with chronic airway pseudomonas infection and this is paralleled by a reduction in bacterial density in the lungs. |
| PubMedID- 22396480 | This is particularly true for the treatment of pseudomonas infection in patients with cystic fibrosis. |
| PubMedID- 25632992 | Regulatory t-cell impairment in cystic fibrosis patients with chronic pseudomonas infection. |
Page: 1